Clinical trial
Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In…
NCT00364182 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00364182 |
|---|---|
| Title | Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B |
| Official title | A Multicenter, Open-Label Study To Compare On-Demand Treatment With 2 Prophylaxis Regimens of Recombinant Coagulation Factor IX (BeneFIX) Reformulated Drug Product (rFIX-R) In Subjects With Severe Hemophilia B |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemophilia B |
| Intervention type | Drug |
| Interventions | Recombinant Coagulation Factor IX (BeneFIX) |
| Enrollment | 50 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Aug 15, 2006 |
| Last update posted | Oct 4, 2011 |
| Countries | Canada, Croatia, Hungary, Italy, Romania, Russia, Serbia, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: